Vitamin D levels are not associated with non-alcoholic fatty liver disease severity in a Brazilian population
Abstract
Abstract. Some epidemiological evidence suggests an inverse correlation between non-alcoholic fatty liver disease (NAFLD) frequency and vitamin D levels. Likewise, a beneficial effect of vitamin D on diabetes mellitus (DM) and insulin resistance has been observed, but this is an unsolved issue. Thus, we aimed to investigate the prevalence of hypovitaminosis D in a NAFLD Brazilian population and its association with disease severity and presence of comorbidities. In a cross-sectional study, the clinical, biochemical and histological parameters of 139 NAFLD patients were evaluated according to two different cut-off points of serum 25-hydroxyvitamin D levels (20 ng/mL and 30 ng/mL). The mean age of the population was 56 ± 16 years, most patients were female (83%), 72% had hypertension, 88% dyslipidemia, 46% DM, 98% central obesity, and 82% metabolic syndrome. Serum vitamin D levels were < 30 ng/mL in 78% of the patients, and < 20 ng/mL in 35%. The mean vitamin D level was 24.3 ± 6.8 ng/mL. The comparison between the clinical, biochemical and histological characteristics of the patients according to the levels of vitamin D showed no significant difference. Most patients with NAFLD had hypovitaminosis D, but low vitamin D levels were not related to disease severity and the presence of comorbidities.
References
1 The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55(6):2005–23.
2 . The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol. 2013;10(11):686–90.
3 The natural history of nonalcoholic fatty liver disease: A population-based cohort study. Gastroenterology. 2005;129(1):113–21.
4 . Systematic review: The epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34(3):274–85.
5 . Vitamin D and nonalcoholic fatty liver disease (NAFLD): Is it more than just an association? Hepatology. 2013;58(3):1166–74.
6 Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly chinese individuals. Diabetes Care. 2009;32(7):1278–83.
7 . D-livering the message: The importance of vitamin D status in chronic liver disease. J Hepatol. 2012;57(4):897–909.
8 . Vitamin D and type 2 diabetes: A systematic review. Eur J Clin Nutr. 2011;65(9):1005–15.
9 . Effect of vitamin D supplementation on glycaemic control and insulin resistance: A systematic review and meta-analysis. Diabet Med. 2012;29(8):e142–50.
10 Correlation between serum 25-OH vitamin D expression and non-alcoholic fatty liver disease. Exp Ther Med. 2020;19(3):1681–6.
11 . Association of nonalcoholic fatty liver disease with serum vitamin D levels in combination of physical fitness in Korean older adults. J Steroid Biochem Mol Biol. 2020;198:105569.
12 . Development of non-alcoholic fatty liver disease (NAFLD) in young obese tribal subjects of Tripura: Link between low 25 (OH) vitamin-D levels and immune modulators. J Assoc Physicians India. 2019;67(8):52–6.
13 . Low vitamin D level was associated with metabolic syndrome and high leptin level in subjects with nonalcoholic fatty liver disease: A community-based study. BMC Gastroenterol. 2019;19(1):126.
14 . Strong association between serum vitamin D and vaspin levels, AIP, VAI and liver enzymes in NAFLD patients. Int J Vitam Nutr Res. 2020;90(1–2):59–66.
15 Association between vitamin D status and non-alcoholic fatty liver disease: A population-based study. J Nutr Sci Vitaminol (Tokyo). 2019;65:303–8.
16 Vitamin D status and non-alcoholic fatty liver disease in patients with type 1 diabetes. J Endocrinol Invest. 2019;42(9):1099–107.
17 No evidence for lower levels of serum vitamin D in the presence of hepatic steatosis: A study on the Portuguese general population. Int J Med Sci. 2018;15(14):1778–86.
18 . Metabolic syndrome: A new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23(5):469–80.
19 . Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486–97.
20 . A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009;2(5–6):231–7.
21 . Body fat distribution and non communicable diseases in populations: Overview of the 2008 WHO Expert Consultation on Waist Circumference and Waist-Hip Ratio. Eur J Clin Nutr. 2010;64(1):2–5.
22 . Physical status: The use and interpretation of anthropometry. Report of a WHO Expert Committee. Technical Report Series No. 854. Geneva: WHO; 1995:1–452.
23 . Accuracy and clinical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatography–tandem mass spectrometry as a reference. Ann Clin Biochem. 2008;45(Pt 2):153–9.
24 . Homeostatic model assessment: Insulin resistance and beta-cell function from fasting glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9.
25 . The lipid accumulation product is associated with impaired glucose tolerance in PCOS women. J Clin Endocrinol Metab. 2011;96(6):986–90.
26 The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45(4):846–54.
27 . Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med. 2011;43(8):617–49.
28 Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313–21.
29 . Vitamin D deficiency. N Engl J Med. 2007;357(3):266–81.
30 Evaluation, treatment, and prevention of vitamin d deficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2011;96(7):1911–30.
31 . Estimates of optimal vitamin D status. Osteoporos Int. 2005;16(7):713–6.
32 . Vitamin D and its effects on cardiovascular diseases: A comprehensive review. Korean J Intern Med. 2016;31(6):1018–29.
33 . Vitamin D deficiency – is there really a pandemic? N Engl J Med. 2016;375(19):1817–20.
34 . Dietary reference intakes: Aplicabilidade das tabelas em estudos nutricionais. Rev Nutr. 2006;19(6):741–60.
35 Vitamin D deficiency in older men. J Clin Endocrinol Metab. 2009;94:1214–22.
36 . Prevalência de deficiência e insuficiência de vitamina D e sua correlação com PTH, marcadores de remodelação óssea e densidade mineral óssea, em pacientes ambulatoriais. Arq Bras Endrocrinol Metab. 2008;52(3):482–8.
37 Vitamin D deficiency and seasonal variation over the years in São Paulo, Brazil. Osteoporos Int. 2016;27(12):3449–56.
38 Low serum concentrations of 25-hydroxyvitamin D in children and adolescents with systemic lupus erythematosus. Braz J Med Biol Res. 2014;47(8):721–6.
39 Correlation between 25-hydroxyvitamin D levels and latitude in Brazilian postmenopausal women: From the Arzoxifene Generations Trial. Osteoporos Int. 2013;24(10):2707–12.
40 Recomendações da Sociedade Brasileira de Endocrinologia e Metabologia (SBEM) para o diagnóstico e tratamento da hipovitaminose D. Arq Bras Endocrinol Metab. 2014;58(5):411–33.
41 The association of vitamin D deficiency with nonalcoholic fatty liver disease. Clinics. 2014;69:542–6.
42 Hypovitaminosis D is associated with increased whole body fat mass and greater severity of nonalcoholic fatty liver disease. Liver Int. 2014;34(6):118–27.
43 Serum vitamin D is associated with non-alcoholic fatty liver disease in Chinese males with normal weight and liver enzymes. Acta Pharmacol Sin. 2014;35(9):1150–6.
44 Treatment of non-alcoholic steatohepatitis patients with vitamin D: A double-blinded, randomized, placebo-controlled pilot study. Scand J Gastroenterol. 2018;53(9):1114–20.
45 . Nonalcoholic fatty liver disease and abdominal fat accumulation according to vitamin D status in patients with type 2 diabetes. J Obes Metab Syndr. 2018;27(1):53–60.
46 . Does vitamin D modulate asymmetric dimethylarginine and c-reactive protein concentrations? Am J Med. 2010;123(4):335–41.
47 Low vitamin D levels and non-alcoholic fatty liver disease, evidence for their independent association in men in East China: A cross-sectional study (Survey on Prevalence in East China for Metabolic Diseases and Risk Factors (SPECT-China)). Br J Nutr. 2016;115(8):1352–9.
48 Low 25-hydroxyvitamin D level is not an independent risk factor for hepatosteatosis in obese children. J Pediatr Endocrinol Metab. 2016;29(7):783–8.
49 Severe vitamin D deficiency is not associated with liver damage in morbidly obese patients. Obes Surg. 2016;26(9):2138–43.
50 . Vitamin D levels do not predict the stage of hepatic fibrosis in patients with non-alcoholic fatty liver disease: A PRISMA compliant systematic review and meta-analysis of pooled data. World J Hepatol. 2018;10(1):142–54.
51 . Vitamin D and histologic severity of nonalcoholic fatty liver disease: A systematic review and meta-analysis. Dig Liver Dis. 2017;49(6):618–22.
52 . Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog Lipid Res. 2009;48(1):1–26.
53 . Hypovitaminosis D in patients with type 2 diabetes mellitus: A relation to disease control and complications. ISRN Endocrinology. 2013;2013:641098.
54 Hypovitaminosis D associations with adverse metabolic parameters are accentuated in patients with Type 2 diabetes mellitus: A body mass index-independent role of adiponectin? J Endocrinol Invest. 2013;36(1):1–6.
55 . Vitamin D: A new player in non-alcoholic fatty liver disease? World J Gastroenterol. 2015;21(6):1718–27.
56 Clinical review: Effect of vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: A systematic review and meta-analysis. J Clin Endocrinol Metab. 2014;99(10):3551–60.
57 . Vitamin D and diabetes. Diabetologia. 2005;48(7):1247–57.
58 . Vitamin D deficiency inhibits pancreatic secretion of insulin. Science. 1980;209(4458):823–5.
59 . The vitamin D receptor gene variant and physical activity predicts fasting glucose levels in healthy young men. Diabet Med. 2003;20(6):451–4.
60 The serum vitamin D level is inversely correlated with nonalcoholic fatty liver disease. Clin Mol Hepatol. 2016;22(1):146–51.
61 Association between 25-hydroxyvitamin D and inflammatory biomarker levels in a cross-sectional population-based study, São Paulo, Brazil. Nutr Res. 2016;36(1):1–8.